Survivorship Care Plan: We’ve Got the Tool—It’s Time to Fix the Process
Mené aux Etats-Unis sur 96 patients ayant survécu à un cancer pédiatrique, cet essai randomisé évalue l'efficacité, du point de vue de leur adhésion aux examens de surveillance et de suivi et de la survenue d'événements indésirables liés aux traitements, d'un programme personnalisé de soins dédiés à l'après-cancer
Since the release of the Institute of Medicine recommendation for the provision of a survivorship care plan (SCP), considerable emphasis has been placed on the document. While patients report satisfaction in receiving SCPs (1), preparing them is time consuming (2), they are not routinely provided by oncologists (3), and they have little to no effect on outcomes (4,5). Primary care providers (PCPs) find the information useful but want the SCP to be simple, accessible, and timely (6,7). In a national survey, the few PCPs who received SCPs were nine times more likely to discuss survivorship care with their patients (8). Yet despite the proliferation of SCP studies, there is a continuing debate about target populations, measures, and outcomes (9,10).
JNCI: Journal of the National Cancer Institute , éditorial, 2017